10-QPeriod: Q2 FY2026

AGILENT TECHNOLOGIES, INC. Quarterly Report for Q2 Ended Apr 30, 2026

Filed June 1, 2026For Securities:A

Summary

Agilent Technologies, Inc. reported robust financial results for the period ended April 30, 2026. Total net revenue increased by 10% year-over-year for the quarter and 8% for the six-month period, driven by broad-based growth across all segments and geographic regions. Net income saw a significant increase, reaching $339 million in the quarter and $644 million year-to-date, up from $215 million and $533 million in the prior year, respectively. The company continues to execute on its strategic priorities, including investing in research and development and expanding its product and service portfolio. A notable event was the definitive agreement to acquire BC Midco I, Inc. for approximately $950 million, which is expected to close by the end of fiscal year 2026 and will be integrated into the Life Sciences and Diagnostics Markets segment. Agilent also announced its board declared a quarterly dividend of $0.255 per share. Despite global economic uncertainties, the company has effectively mitigated impacts from geopolitical tensions and tariffs through strategic initiatives.

Financial Highlights

57 data points
Beta

Revenue

$1.83B

54.0% Gross Margin

Net Income

$339.00M

18.5% Net Margin

EPS (Diluted)

$1.20

Total Assets

$13.06B

Cash & Equivalents

$1.81B

Free Cash Flow

$201.00M

Financial Statements
Beta
Revenue$1.83B
Cost of Revenue$845.00M
Gross Profit$990.00M
R&D Expenses$126.00M
SG&A Expenses$465.00M
Operating Expenses$1.44B
Operating Income$399.00M
Interest Expense$25.00M
Net Income$339.00M
EPS (Basic)$1.20
EPS (Diluted)$1.20
Shares Outstanding (Basic)282.00M
Shares Outstanding (Diluted)283.00M

Key Highlights

  • 1Total net revenue increased by 10% in the third quarter and 8% in the first six months of fiscal year 2026 compared to the prior year.
  • 2Net income surged to $339 million in the quarter and $644 million year-to-date, demonstrating strong profitability.
  • 3The company announced a definitive agreement to acquire BC Midco I, Inc. ('Biocare') for approximately $950 million in cash, strengthening its Life Sciences and Diagnostics Markets segment.
  • 4All three operating segments (Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets) contributed to revenue growth.
  • 5The company continued its return of capital to shareholders with a declared quarterly dividend of $0.255 per share.
  • 6Agilent Technologies has effectively navigated global economic uncertainties, including geopolitical tensions and tariff impacts, through strategic mitigation efforts.
  • 7Operating margin improved to 21.7% in the quarter and 18.0% in the prior year, indicating enhanced operational efficiency.

Frequently Asked Questions

Agilent Technologies reported a 10% increase in total net revenue for the three months ended April 30, 2026, reaching $1.835 billion, and an 8% increase for the six months ended April 30, 2026, totaling $3.633 billion, compared to the same periods in the prior year. This growth was broad-based across all segments and geographic regions.

Agilent announced a definitive agreement to acquire BC Midco I, Inc. ('Biocare') for approximately $950 million in cash. This acquisition is strategically important as Biocare is a leading provider of clinical and research solutions and will be integrated into Agilent's Life Sciences and Diagnostics Markets segment, further strengthening its position in this key area.

Agilent successfully mitigated the adverse impacts of global tariffs and geopolitical tensions, including the Middle East conflict. The company implemented various strategies such as supply chain optimization, targeted pricing actions, and cost-efficiency initiatives to protect margins and sustain long-term growth, ensuring these external factors did not materially affect their operational results.

The company remains optimistic about the long-term health of its key end markets and continues to invest in research and development and expand its product and solutions portfolio. They are particularly focused on enhancing customer experience and driving productivity improvements, anticipating a normalization in customer capital spending.